Erman E S, Osidak L V, Sukhovetskaya V F, Drinevskii V P
Institute of Influenza, Russian Academy of Medical Sciences, St. Petersburg.
Bull Exp Biol Med. 2009 Aug;148(2):270-4. doi: 10.1007/s10517-009-0705-x.
Prophylactic efficiency and safety of anaferon (pediatric formulation) in children aging 1?month to 4 years, including sickly children, was proven. The use of the preparation in children reduced the incidence of acute respiratory infections, alleviated the course of the disease, and decreased the incidence of detection of viral antigens in nasal meatuses.